167 related articles for article (PubMed ID: 18456253)
1. Memantine does not show intracellular block of the NMDA receptor channel.
Parsons CG; Gilling KE; Jatzke C
Eur J Pharmacol; 2008 Jun; 587(1-3):99-103. PubMed ID: 18456253
[TBL] [Abstract][Full Text] [Related]
2. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.
Gilling KE; Jatzke C; Hechenberger M; Parsons CG
Neuropharmacology; 2009 Apr; 56(5):866-75. PubMed ID: 19371579
[TBL] [Abstract][Full Text] [Related]
3. Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine.
Gilling KE; Jatzke C; Parsons CG
Neuropharmacology; 2007 Sep; 53(3):415-20. PubMed ID: 17632186
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
[TBL] [Abstract][Full Text] [Related]
5. In vitro galantamine-memantine co-application: mechanism of beneficial action.
Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
[TBL] [Abstract][Full Text] [Related]
6. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.
Medvedev IO; Malyshkin AA; Belozertseva IV; Sukhotina IA; Sevostianova NY; Aliev K; Zvartau EE; Parsons CG; Danysz W; Bespalov AY
Neuropharmacology; 2004 Aug; 47(2):175-83. PubMed ID: 15223296
[TBL] [Abstract][Full Text] [Related]
7. Different capacities of various NMDA receptor antagonists to prevent ischemia-induced neurodegeneration in human cultured NT2 neurons.
Garcia de Arriba S; Wegner F; Grüner K; Verdaguer E; Pallas M; Camins A; Wagner A; Wohlfahrt K; Allgaier C
Neurochem Int; 2006 Oct; 49(5):466-74. PubMed ID: 16650914
[TBL] [Abstract][Full Text] [Related]
8. Antagonist properties of polyamines and bis(ethyl)polyamines at N-methyl-D-aspartate receptors.
Igarashi K; Williams K
J Pharmacol Exp Ther; 1995 Mar; 272(3):1101-9. PubMed ID: 7891322
[TBL] [Abstract][Full Text] [Related]
9. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.
Bresink I; Benke TA; Collett VJ; Seal AJ; Parsons CG; Henley JM; Collingridge GL
Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398
[TBL] [Abstract][Full Text] [Related]
10. Mg2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes.
Wrighton DC; Baker EJ; Chen PE; Wyllie DJ
J Physiol; 2008 Jan; 586(1):211-25. PubMed ID: 17962329
[TBL] [Abstract][Full Text] [Related]
11. Blocking kinetics of memantine on NR1a/2A receptors recorded in inside-out and outside-out patches from Xenopus oocytes.
Parsons CG; Gilling KE; Jatzke C
J Neural Transm (Vienna); 2008 Oct; 115(10):1367-73. PubMed ID: 18607526
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo.
Masuko T; Suzuki T; Miyake M; Kusama-Eguchi K; Kizawa Y; Tomono K; Kashiwagi K; Igarashi K; Kusama T
Neurosci Lett; 2012 Jan; 506(2):251-5. PubMed ID: 22119002
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels.
Chen HS; Lipton SA
J Pharmacol Exp Ther; 2005 Sep; 314(3):961-71. PubMed ID: 15901795
[TBL] [Abstract][Full Text] [Related]
14. Differences in degree of trapping of low-affinity uncompetitive N-methyl-D-aspartic acid receptor antagonists with similar kinetics of block.
Mealing GA; Lanthorn TH; Murray CL; Small DL; Morley P
J Pharmacol Exp Ther; 1999 Jan; 288(1):204-10. PubMed ID: 9862772
[TBL] [Abstract][Full Text] [Related]
15. Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor.
Masuko T; Nagaoka H; Miyake M; Metori K; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
Neurochem Int; 2007 Jan; 50(2):443-9. PubMed ID: 17113196
[TBL] [Abstract][Full Text] [Related]
16. Memantine as an example of a fast, voltage-dependent, open channel N-methyl-D-aspartate receptor blocker.
Parsons CG; Gilling K
Methods Mol Biol; 2007; 403():15-36. PubMed ID: 18827985
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors.
Maskell PD; Speder P; Newberry NR; Bermudez I
Br J Pharmacol; 2003 Dec; 140(7):1313-9. PubMed ID: 14645141
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the alpha9alpha10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-D-aspartate receptors.
Plazas PV; Savino J; Kracun S; Gomez-Casati ME; Katz E; Parsons CG; Millar NS; Elgoyhen AB
Eur J Pharmacol; 2007 Jul; 566(1-3):11-9. PubMed ID: 17466293
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity.
Volbracht C; van Beek J; Zhu C; Blomgren K; Leist M
Eur J Neurosci; 2006 May; 23(10):2611-22. PubMed ID: 16817864
[TBL] [Abstract][Full Text] [Related]
20. Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors.
Kloda A; Clements JD; Lewis RJ; Adams DJ
Mol Pharmacol; 2004 Jun; 65(6):1386-96. PubMed ID: 15155832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
